JUBLINGREA665.85

Jubilant Ingrevia Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersVIDHIINGPARADEEPPCBLFACTOALIGPLPAUSHAKLTDTIRUMALCHMMcap ₹6.7 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations1,019.9966.41,074.41,024.31,045.21,056.81,051.31,038.01,120.71,051.01,178.71,300.3
Other Income8.58.89.59.610.59.48.411.210.89.49.310.2
Total Income1,028.5975.21,083.91,033.91,055.71,066.21,059.61,049.21,131.51,060.41,188.01,310.5
Expenses
+ Cost of Materials Consumed472.7501.1487.6532.0511.8525.4481.1448.9548.0510.4597.4717.7
+ Purchases of Stock-in-Trade14.118.113.47.48.29.032.232.430.641.744.464.1
+ Changes in Inventories18.5-10.794.9-10.8-12.84.219.638.122.04.0-23.0-153.2
+ Employee Benefit Expense103.5101.185.9101.5112.7105.296.0108.2107.5103.6106.3117.4
+ Finance Costs12.515.113.614.315.112.413.912.712.212.511.817.4
+ Depreciation & Amortisation33.934.235.738.939.639.839.440.841.245.048.451.0
+ Other Expenses293.6261.1301.3284.7300.9274.7275.6268.1277.2264.8291.0355.2
Total Expenses948.7920.11,032.5968.0975.3970.6957.9949.31,038.6981.91,076.21,169.6
EBITDA117.795.691.2109.5124.6138.3146.7142.1135.5126.6162.6199.1
EBIT83.861.355.570.785.098.5107.3101.394.381.5114.2148.1
Profit
PBT before Exceptional Items79.855.151.466.080.495.6101.899.892.978.5111.7140.9
+ Exceptional Items0.00.00.00.0-0.10.00.00.00.0-13.00.00.0
Pretax Income79.855.151.466.080.295.6101.899.892.965.4111.7140.9
+ Current Tax12.711.922.312.525.522.025.323.215.318.227.543.0
+ Deferred Tax9.74.6-0.24.8-4.34.22.51.58.10.3-2.2-7.9
Tax Expense22.416.522.117.321.226.227.724.723.418.525.335.0
+ Share of Associates & JVs0.10.0-0.10.10.00.00.0-0.1-0.1-0.0-0.0-0.0
Net Income57.538.629.348.759.069.474.175.169.546.986.4105.8
+ Net Income — Continuing Ops57.438.529.348.759.069.474.075.269.646.986.5105.9
+ Other Comprehensive Income-0.40.83.31.61.5-7.46.010.17.50.72.15.1
Total Comprehensive Income57.139.332.650.460.562.080.185.276.947.688.6110.9
Net Income to Common57.538.629.348.759.069.474.175.169.546.986.4105.8
Per Share
Basic EPS3.642.441.853.083.734.394.694.754.402.975.476.70
Diluted EPS3.642.431.853.083.734.394.644.754.402.975.396.68
Other Comprehensive Income — detail
+ Other Comprehensive Income6.010.17.50.72.15.1
+ Items NOT to be Reclassified to P&L-1.3-1.35.42.0-3.0-1.80.91.64.4-1.2-3.92.7
+ Tax on Items NOT to be Reclassified0.30.20.40.1-0.50.4
+ Tax on Items NOT to be Reclassified — alt tag-0.6-0.41.20.0-0.7-0.2
+ Items to be Reclassified to P&L-0.63.3-1.9-0.65.6-6.05.111.84.42.67.41.8
+ Tax on Items to be Reclassified-0.33.20.90.71.9-1.0
+ Tax on Items to be Reclassified — alt tag-0.91.6-1.0-0.31.8-0.2
Comprehensive Income — Owners of Parent57.139.332.650.460.562.06.085.276.947.62.15.1
Per Share — as-filed variants
Basic EPS — Continuing Operations3.642.441.853.083.734.394.694.754.402.975.476.70
Diluted EPS — Continuing Operations3.642.431.853.083.734.394.644.754.402.975.396.68
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit514.7457.8478.5495.8538.1518.1518.3518.5520.2494.9559.9671.7
Gross Margin %50.4647.3744.5448.4051.4849.0349.3049.9646.4247.0947.5051.66
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)79.855.151.466.080.495.6101.899.892.978.5111.7140.9
− Exceptional Items (reconciliation)0.00.00.00.0-0.10.00.00.00.0-13.00.00.0
Net Income Adj (tax-effected)57.538.629.348.759.169.474.175.169.556.386.4105.8
EPS Adj3.642.441.853.083.744.394.694.754.403.565.476.70
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.001.001.001,581.001.001,580.001,580.001,577.001,577.00
Filed Debt Equity0.000.000.000.000.000.000.000.000.00
Filed Dscr0.070.080.090.060.060.050.050.050.05
Filed Iscr0.070.080.090.120.110.120.120.150.12
Paid Up Equity Capital15.815.815.815.815.815.815.815.815.815.815.815.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.